Pituitary-Tumor Endocrinopathies Pituitary adenomas account for about 15% of intracranial
tumors. Clinical manifestations of disease reflect the oversecretion of the involved hormone …

Thyrotropin-secreting pituitary adenomas (TSH-omas) present with signs and symptoms of
hyperthyroidism and they are characterized by elevated serum levels of free thyroid …

Giant pituitary adenomas comprise about 6–10% of all pituitary tumors. They are mostly
clinically non-functioning adenomas and occur predominantly in males. The presenting …

Non-functioning pituitary neuroendocrine tumors do not cause endocrine symptoms related
to hypersecretion of adenohypophyseal hormones and are clinically characterized by …

Somatostatin analogs, such as octreotide, lanreotide, and pasireotide, which function as
somatostatin receptor ligands (SRLs), are the main drugs used for the treatment of …

Abstract Thyrotropin (TSH)-secreting adenomas (TSHomas) are the rarest form of pituitary
adenomas, and most endocrinologists will see few cases in a lifetime, if any. In most cases …

Purpose TSH-secreting pituitary adenomas are rare pituitary tumors. An efficient treatment is
essential to limit the mortality and morbidity in untreated patients. The aim of this study is to …

Normal or elevated thyrotropin (TSH) levels in hyperthyroid patients are characteristic of rare
TSH-secreting pituitary adenoma (TSH-oma), which is easily detectable by computed …

Pituitary adenomas (PAs) are defined as benign monoclonal tumors in the pituitary gland
that cause symptoms due to either hormonal hypersecretion or a space-occupying effect …

Thyrotropin (TSH)-secreting pituitary tumors are the rarest functioning pituitary tumors.
Nonetheless, they are not infrequently plurihormonal, as they may express/secrete …